A Pilot Study of Vorinostat to Restore Sensitivity to Aromatase Inhibitor Therapy Part B
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 May 2018
At a glance
- Drugs Vorinostat (Primary) ; Anastrozole; Exemestane; Letrozole
- Indications Advanced breast cancer; Male breast cancer
- Focus Registrational; Therapeutic Use
- 13 Apr 2018 Planned End Date changed from 1 Dec 2017 to 1 Jan 2020.
- 04 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 16 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History